Risperdal Gynecomastia Reports Among Young Boys Add To The Drug’s Troubled History
Written by Stephen Fields on April 28, 2015
According to a growing a number of angry families, Johnson & Johnson’s popular antipsychotic Risperdal does more harm than good. Worse, the manufacturer failed to sufficiently warn parents about the drug’s potential side effects. Evidence suggests a potential Risperdal breast growth connection in young boys.